Panel COVERS Problems With Cephalon’s Fentora

Risk-management plan is “impressive,” but needs supporting evidence, FDA advisors say.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet